Press Releases

STOCKHOLM, Feb. 19, 2020 /PRNewswire/ --Important events in 2019KL1333            NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study            NeuroVive initiates

HAIFA, Israel, Feb. 19, 2020 /PRNewswire/ --  ViAqua Therapeutics ("ViAqua") announced the achievement of a number of key milestones in its quest to provide a solution to enhance shrimp health, thereby  

LINKÖPING, Sweden, Feb. 19, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received an order for its radiology imaging solution from the B

ENGLEWOOD, Colo., Feb. 18, 2020 /PRNewswire/ -- Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help streamline procedures, allow surgeons flexibility in technique and approach, an

SEOUL, South Korea, Feb. 18, 2020 /PRNewswire/ -- UBM BN Co., Ltd., the fair manager of SECON 2020 originally scheduled for 18 - 20 March 2020 has made the decision to reschedule the event to 6 - 8 July at KINTEX, Korea.

WASHINGTON, Feb. 18, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2019 on Tuesday, February 25, 2020, after the market closes.  Vanda will host a conference call at 4:30 PM ET on Tuesday, Februa

KUALA LUMPUR, Malaysia, Feb. 18, 2020 /PRNewswire/ -- ASIAWATER 2020 originally scheduled from March 31- April 1, 2020 has now moved to the revised dates of 30 November – 2 December, 2020 at the Kuala Lumpur Convention Center (KLCC).  According to Inform

SEOUL, South Korea, Feb. 18, 2020 /PRNewswire/ -- Amorepacific R&D Center opened Green Tea Probiotics Research Center to deepen the study of lactobacillus newly found in Jeju organic green tea garden and to continue the development of innovative products in microorganisms and other fields. 

PERTH, Australia, Feb. 18, 2020 /PRNewswire/ --Teleconference 11am (AEDT) today with

NEW YORK, Feb. 18, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. ("LogicBio" or the "Company") (NASDAQ: LOGC).  Such investors are advised to contact Robert S. Willoughby at